CVRx Inc
$ 7.24
6.63%
24 Feb - close price
- Market Cap 178,656,000 USD
- Current Price $ 7.24
- High / Low $ 7.61 / 6.76
- Stock P/E N/A
- Book Value 1.50
- EPS -2.04
- Next Earning Report 2026-04-29
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.27 %
- ROE -0.97 %
- 52 Week High 14.02
- 52 Week Low 4.30
About
CVRx, Inc. develops implantable technology for the treatment of patients with high blood pressure / hypertension and heart failure.
Analyst Target Price
$11.17
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-01-22 | 2025-11-04 | 2025-08-04 | 2025-05-08 | 2025-02-04 | 2024-10-29 | 2024-07-29 | 2024-04-30 | 2024-01-25 | 2023-10-26 | 2023-07-25 | 2023-04-27 |
| Reported EPS | -0.46 | -0.49 | -0.57 | -0.53 | -0.43 | -0.57 | -0.65 | -1.04 | -0.44 | -0.43 | -0.56 | -0.55 |
| Estimated EPS | -0.4446 | -0.5 | -0.52 | -0.57 | -0.38 | -0.47 | -0.55 | -0.54 | -0.54 | -0.58 | -0.58 | -0.56 |
| Surprise | -0.0154 | 0.01 | -0.05 | 0.04 | -0.05 | -0.1 | -0.1 | -0.5 | 0.1 | 0.15 | 0.02 | 0.01 |
| Surprise Percentage | -3.4638% | 2% | -9.6154% | 7.0175% | -13.1579% | -21.2766% | -18.1818% | -92.5926% | 18.5185% | 25.8621% | 3.4483% | 1.7857% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-29 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.5 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CVRX
2026-02-24 02:10:00
This article analyzes Cvrx Inc. (NASDAQ: CVRX), highlighting a near-term strong sentiment challenging persistent mid and long-term weakness. It identifies a significant risk-reward short setup and outlines three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also provides multi-timeframe signal strengths and support/resistance levels.
2026-02-23 19:32:12
CVRX stock has risen 9% today with $3.7 million in trading volume, making it the 505th most-searched ticker on Quiver Quantitative. Insider trading data shows 8 transactions in the past 6 months, with 2 purchases and 6 sales. Hedge fund activity reveals 37 institutional investors increasing their positions and 54 decreasing them in the last quarter, while analysts have issued 1 buy rating and a median price target of $11.5 from two analysts.
2026-02-23 12:21:34
CVRx director Jain Mudit K. recently purchased 46,800 shares of common stock for a total of $297,591 on February 20, 2026. This transaction comes amidst a 23% surge in the company's stock value over the past week. The director now directly holds 5,650 shares and indirectly 980,183 shares through Treo Ventures I, L.P. The company also reported a slight miss on fourth-quarter 2025 EPS but exceeded revenue expectations, with Canaccord Genuity maintaining a Buy rating but lowering the stock price target.
2026-02-23 11:44:09
A director at CVRX, Mudit K. Jain, recently purchased 46,800 shares of the company's stock for an estimated $297,591, increasing his holdings by 5.0%. This transaction is part of broader insider trading activity, which includes 2 purchases and 6 sales in the past six months, and significant adjustments in institutional holdings with 36 investors adding and 54 decreasing their positions. Analysts maintain a "Buy" rating on CVRX, with price targets ranging from $10.0 to $13.0.
2026-02-19 20:06:00
Pomerantz LLP is investigating potential securities fraud claims against CVRx, Inc. (NASDAQ: CVRX) on behalf of its investors. The investigation follows two significant stock price drops in 2025 after the company announced weaker-than-expected quarterly results and lowered its revenue guidance due to salesforce issues. Investors affected by these events are encouraged to contact the law firm.
2026-02-19 14:03:00
Glancy Prongay Wolke & Rotter LLP has announced a securities fraud investigation into CVRx, Inc. (CVRX) following significant stock price drops due to disappointing revenue figures and issues with salesforce integration. The law firm is urging shareholders who experienced losses to contact them to inquire about recovering their investments. The investigation focuses on CVRx's potential violations of federal securities laws after multiple announcements of lower-than-anticipated revenue and challenges with new sales representatives.
